nodes	percent_of_prediction	percent_of_DWPC	metapath
Dapagliflozin—CYP2D6—Parkinson's disease	0.411	0.583	CbGaD
Dapagliflozin—ABCB1—Parkinson's disease	0.294	0.417	CbGaD
Dapagliflozin—SLC5A11—forebrain—Parkinson's disease	0.00681	0.0948	CbGeAlD
Dapagliflozin—SLC5A11—medulla oblongata—Parkinson's disease	0.00492	0.0685	CbGeAlD
Dapagliflozin—SLC5A11—midbrain—Parkinson's disease	0.0045	0.0626	CbGeAlD
Dapagliflozin—SLC5A11—spinal cord—Parkinson's disease	0.00439	0.0611	CbGeAlD
Dapagliflozin—SLC5A4—head—Parkinson's disease	0.0043	0.0598	CbGeAlD
Dapagliflozin—SLC5A4—nervous system—Parkinson's disease	0.00407	0.0567	CbGeAlD
Dapagliflozin—SLC5A4—central nervous system—Parkinson's disease	0.00392	0.0546	CbGeAlD
Dapagliflozin—SLC5A11—head—Parkinson's disease	0.0039	0.0543	CbGeAlD
Dapagliflozin—SLC5A11—nervous system—Parkinson's disease	0.0037	0.0515	CbGeAlD
Dapagliflozin—SLC5A1—cardiovascular system—Parkinson's disease	0.00364	0.0507	CbGeAlD
Dapagliflozin—SLC5A11—central nervous system—Parkinson's disease	0.00356	0.0496	CbGeAlD
Dapagliflozin—SLC5A11—cerebellum—Parkinson's disease	0.00348	0.0484	CbGeAlD
Dapagliflozin—UGT2B4—cardiovascular system—Parkinson's disease	0.00336	0.0467	CbGeAlD
Dapagliflozin—SLC5A4—brain—Parkinson's disease	0.00311	0.0433	CbGeAlD
Dapagliflozin—SLC5A11—brain—Parkinson's disease	0.00283	0.0393	CbGeAlD
Dapagliflozin—Canagliflozin—ABCB1—Parkinson's disease	0.00281	1	CrCbGaD
Dapagliflozin—CYP2D6—hindbrain—Parkinson's disease	0.00106	0.0147	CbGeAlD
Dapagliflozin—CYP2A6—cerebellum—Parkinson's disease	0.0008	0.0111	CbGeAlD
Dapagliflozin—CYP2C9—cardiovascular system—Parkinson's disease	0.000661	0.00919	CbGeAlD
Dapagliflozin—CYP2A6—brain—Parkinson's disease	0.00065	0.00905	CbGeAlD
Dapagliflozin—CYP2D6—brainstem—Parkinson's disease	0.000607	0.00845	CbGeAlD
Dapagliflozin—CYP2D6—forebrain—Parkinson's disease	0.000586	0.00816	CbGeAlD
Dapagliflozin—ABCB1—embryo—Parkinson's disease	0.000477	0.00664	CbGeAlD
Dapagliflozin—CYP1A1—head—Parkinson's disease	0.000465	0.00647	CbGeAlD
Dapagliflozin—CYP1A1—nervous system—Parkinson's disease	0.000441	0.00613	CbGeAlD
Dapagliflozin—CYP1A1—central nervous system—Parkinson's disease	0.000424	0.0059	CbGeAlD
Dapagliflozin—ABCB1—forebrain—Parkinson's disease	0.000422	0.00587	CbGeAlD
Dapagliflozin—ABCB1—cardiovascular system—Parkinson's disease	0.000357	0.00496	CbGeAlD
Dapagliflozin—CYP1A1—brain—Parkinson's disease	0.000337	0.00469	CbGeAlD
Dapagliflozin—CYP2D6—head—Parkinson's disease	0.000336	0.00467	CbGeAlD
Dapagliflozin—CYP3A4—nervous system—Parkinson's disease	0.000323	0.0045	CbGeAlD
Dapagliflozin—CYP2D6—nervous system—Parkinson's disease	0.000318	0.00443	CbGeAlD
Dapagliflozin—CYP3A4—central nervous system—Parkinson's disease	0.000311	0.00433	CbGeAlD
Dapagliflozin—CYP2D6—central nervous system—Parkinson's disease	0.000306	0.00426	CbGeAlD
Dapagliflozin—ABCB1—medulla oblongata—Parkinson's disease	0.000305	0.00424	CbGeAlD
Dapagliflozin—CYP2D6—cerebellum—Parkinson's disease	0.000299	0.00417	CbGeAlD
Dapagliflozin—ABCB1—midbrain—Parkinson's disease	0.000278	0.00388	CbGeAlD
Dapagliflozin—ABCB1—spinal cord—Parkinson's disease	0.000272	0.00378	CbGeAlD
Dapagliflozin—CYP2D6—brain—Parkinson's disease	0.000243	0.00339	CbGeAlD
Dapagliflozin—ABCB1—head—Parkinson's disease	0.000241	0.00336	CbGeAlD
Dapagliflozin—ABCB1—nervous system—Parkinson's disease	0.000229	0.00319	CbGeAlD
Dapagliflozin—ABCB1—central nervous system—Parkinson's disease	0.00022	0.00307	CbGeAlD
Dapagliflozin—ABCB1—cerebellum—Parkinson's disease	0.000215	0.003	CbGeAlD
Dapagliflozin—ABCB1—brain—Parkinson's disease	0.000175	0.00244	CbGeAlD
Dapagliflozin—ABCB1—Transmembrane transport of small molecules—SLC18A2—Parkinson's disease	4.28e-05	0.000194	CbGpPWpGaD
Dapagliflozin—ABCB1—Allograft Rejection—TNF—Parkinson's disease	4.24e-05	0.000192	CbGpPWpGaD
Dapagliflozin—ABCB1—Metabolism—MCCC1—Parkinson's disease	4.23e-05	0.000192	CbGpPWpGaD
Dapagliflozin—ABCB1—Metabolism—ND3—Parkinson's disease	4.23e-05	0.000192	CbGpPWpGaD
Dapagliflozin—UGT2B4—Metabolism—INS—Parkinson's disease	4.23e-05	0.000192	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism of lipids and lipoproteins—PLA2G6—Parkinson's disease	4.2e-05	0.000191	CbGpPWpGaD
Dapagliflozin—UGT1A9—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	4.11e-05	0.000187	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism of lipids and lipoproteins—CTGF—Parkinson's disease	4.07e-05	0.000185	CbGpPWpGaD
Dapagliflozin—CYP3A4—Biological oxidations—COMT—Parkinson's disease	4.02e-05	0.000183	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism—FBP1—Parkinson's disease	4.02e-05	0.000182	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism—GBA—Parkinson's disease	4.02e-05	0.000182	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism—DBH—Parkinson's disease	4.02e-05	0.000182	CbGpPWpGaD
Dapagliflozin—CYP3A4—Biological oxidations—GSTP1—Parkinson's disease	4e-05	0.000182	CbGpPWpGaD
Dapagliflozin—CYP3A4—Biological oxidations—MAOA—Parkinson's disease	3.99e-05	0.000181	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—ND3—Parkinson's disease	3.99e-05	0.000181	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—MCCC1—Parkinson's disease	3.99e-05	0.000181	CbGpPWpGaD
Dapagliflozin—ABCB1—Metabolism—TALDO1—Parkinson's disease	3.98e-05	0.000181	CbGpPWpGaD
Dapagliflozin—ABCB1—Metabolism—OMD—Parkinson's disease	3.98e-05	0.000181	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metapathway biotransformation—COMT—Parkinson's disease	3.97e-05	0.00018	CbGpPWpGaD
Dapagliflozin—CYP2A6—Metabolism—DDC—Parkinson's disease	3.96e-05	0.00018	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—MCCC1—Parkinson's disease	3.96e-05	0.00018	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—ND3—Parkinson's disease	3.96e-05	0.00018	CbGpPWpGaD
Dapagliflozin—UGT2B7—Metabolism—CYP2D6—Parkinson's disease	3.95e-05	0.000179	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metapathway biotransformation—GSTP1—Parkinson's disease	3.95e-05	0.000179	CbGpPWpGaD
Dapagliflozin—ABCB1—Transmembrane transport of small molecules—CP—Parkinson's disease	3.93e-05	0.000179	CbGpPWpGaD
Dapagliflozin—UGT2B7—Metabolism—CTGF—Parkinson's disease	3.88e-05	0.000176	CbGpPWpGaD
Dapagliflozin—ABCB1—Metabolism—NDUFB11—Parkinson's disease	3.77e-05	0.000171	CbGpPWpGaD
Dapagliflozin—SLC5A4—Disease—IL6—Parkinson's disease	3.77e-05	0.000171	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—TALDO1—Parkinson's disease	3.75e-05	0.00017	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—OMD—Parkinson's disease	3.75e-05	0.00017	CbGpPWpGaD
Dapagliflozin—CYP2A6—Metabolism—GSTA4—Parkinson's disease	3.74e-05	0.00017	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—TALDO1—Parkinson's disease	3.72e-05	0.000169	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—OMD—Parkinson's disease	3.72e-05	0.000169	CbGpPWpGaD
Dapagliflozin—CYP3A4—Biological oxidations—GSTM1—Parkinson's disease	3.68e-05	0.000167	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metapathway biotransformation—GSTM1—Parkinson's disease	3.63e-05	0.000165	CbGpPWpGaD
Dapagliflozin—UGT2B7—Metabolism—CYP2E1—Parkinson's disease	3.61e-05	0.000164	CbGpPWpGaD
Dapagliflozin—ABCB1—Metabolism—GCH1—Parkinson's disease	3.6e-05	0.000163	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism of lipids and lipoproteins—PLA2G6—Parkinson's disease	3.59e-05	0.000163	CbGpPWpGaD
Dapagliflozin—UGT2B7—Metabolism—NQO1—Parkinson's disease	3.57e-05	0.000162	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—NDUFB11—Parkinson's disease	3.56e-05	0.000161	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—NDUFB11—Parkinson's disease	3.53e-05	0.00016	CbGpPWpGaD
Dapagliflozin—UGT2B7—Metabolism—TH—Parkinson's disease	3.52e-05	0.00016	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—GCH1—Parkinson's disease	3.39e-05	0.000154	CbGpPWpGaD
Dapagliflozin—UGT2B7—Metabolism—CYCS—Parkinson's disease	3.38e-05	0.000154	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—MCCC1—Parkinson's disease	3.38e-05	0.000153	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—ND3—Parkinson's disease	3.38e-05	0.000153	CbGpPWpGaD
Dapagliflozin—CYP2A6—Metabolism—PLA2G6—Parkinson's disease	3.37e-05	0.000153	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—GCH1—Parkinson's disease	3.36e-05	0.000153	CbGpPWpGaD
Dapagliflozin—CYP2A6—Metabolism—MAOB—Parkinson's disease	3.33e-05	0.000151	CbGpPWpGaD
Dapagliflozin—UGT1A9—Metabolism—CYP2D6—Parkinson's disease	3.21e-05	0.000146	CbGpPWpGaD
Dapagliflozin—ABCB1—Metabolism—GBA—Parkinson's disease	3.21e-05	0.000146	CbGpPWpGaD
Dapagliflozin—ABCB1—Metabolism—FBP1—Parkinson's disease	3.21e-05	0.000146	CbGpPWpGaD
Dapagliflozin—ABCB1—Metabolism—DBH—Parkinson's disease	3.21e-05	0.000146	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—OMD—Parkinson's disease	3.18e-05	0.000144	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—TALDO1—Parkinson's disease	3.18e-05	0.000144	CbGpPWpGaD
Dapagliflozin—UGT1A9—Metabolism—CTGF—Parkinson's disease	3.15e-05	0.000143	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism of lipids and lipoproteins—CTGF—Parkinson's disease	3.03e-05	0.000138	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—DBH—Parkinson's disease	3.02e-05	0.000137	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—FBP1—Parkinson's disease	3.02e-05	0.000137	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—GBA—Parkinson's disease	3.02e-05	0.000137	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—NDUFB11—Parkinson's disease	3.01e-05	0.000137	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—DBH—Parkinson's disease	3e-05	0.000136	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—FBP1—Parkinson's disease	3e-05	0.000136	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—GBA—Parkinson's disease	3e-05	0.000136	CbGpPWpGaD
Dapagliflozin—UGT2B7—Metabolism—COMT—Parkinson's disease	3e-05	0.000136	CbGpPWpGaD
Dapagliflozin—UGT2B7—Metabolism—GSTP1—Parkinson's disease	2.98e-05	0.000135	CbGpPWpGaD
Dapagliflozin—UGT2B7—Metabolism—MAOA—Parkinson's disease	2.97e-05	0.000135	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism—DDC—Parkinson's disease	2.95e-05	0.000134	CbGpPWpGaD
Dapagliflozin—UGT2B7—Metabolism—HMOX1—Parkinson's disease	2.94e-05	0.000133	CbGpPWpGaD
Dapagliflozin—UGT1A9—Metabolism—CYP2E1—Parkinson's disease	2.94e-05	0.000133	CbGpPWpGaD
Dapagliflozin—UGT1A9—Metabolism—NQO1—Parkinson's disease	2.9e-05	0.000132	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—GCH1—Parkinson's disease	2.87e-05	0.00013	CbGpPWpGaD
Dapagliflozin—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—Parkinson's disease	2.87e-05	0.00013	CbGpPWpGaD
Dapagliflozin—UGT1A9—Metabolism—TH—Parkinson's disease	2.86e-05	0.00013	CbGpPWpGaD
Dapagliflozin—SLC5A1—Disease—IL6—Parkinson's disease	2.86e-05	0.00013	CbGpPWpGaD
Dapagliflozin—SLC5A2—Disease—IL6—Parkinson's disease	2.86e-05	0.00013	CbGpPWpGaD
Dapagliflozin—UGT2B7—Metabolism—ABCB1—Parkinson's disease	2.82e-05	0.000128	CbGpPWpGaD
Dapagliflozin—ABCB1—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	2.8e-05	0.000127	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism—GSTA4—Parkinson's disease	2.78e-05	0.000126	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism of lipids and lipoproteins—GPX1—Parkinson's disease	2.75e-05	0.000125	CbGpPWpGaD
Dapagliflozin—UGT1A9—Metabolism—CYCS—Parkinson's disease	2.75e-05	0.000125	CbGpPWpGaD
Dapagliflozin—UGT2B7—Metabolism—GSTM1—Parkinson's disease	2.74e-05	0.000124	CbGpPWpGaD
Dapagliflozin—ABCB1—Transmembrane transport of small molecules—CYCS—Parkinson's disease	2.69e-05	0.000122	CbGpPWpGaD
Dapagliflozin—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK8—Parkinson's disease	2.64e-05	0.00012	CbGpPWpGaD
Dapagliflozin—UGT2B7—Metabolism—GPX1—Parkinson's disease	2.62e-05	0.000119	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—ND3—Parkinson's disease	2.61e-05	0.000118	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—MCCC1—Parkinson's disease	2.61e-05	0.000118	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism of lipids and lipoproteins—CTGF—Parkinson's disease	2.59e-05	0.000118	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—GBA—Parkinson's disease	2.56e-05	0.000116	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—DBH—Parkinson's disease	2.56e-05	0.000116	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—FBP1—Parkinson's disease	2.56e-05	0.000116	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism—PLA2G6—Parkinson's disease	2.51e-05	0.000114	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism—MAOB—Parkinson's disease	2.48e-05	0.000113	CbGpPWpGaD
Dapagliflozin—CYP2A6—Metabolism—CYP2D6—Parkinson's disease	2.48e-05	0.000112	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—TALDO1—Parkinson's disease	2.45e-05	0.000111	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—OMD—Parkinson's disease	2.45e-05	0.000111	CbGpPWpGaD
Dapagliflozin—UGT1A9—Metabolism—COMT—Parkinson's disease	2.43e-05	0.00011	CbGpPWpGaD
Dapagliflozin—CYP2A6—Metabolism—CTGF—Parkinson's disease	2.43e-05	0.00011	CbGpPWpGaD
Dapagliflozin—UGT1A9—Metabolism—GSTP1—Parkinson's disease	2.42e-05	0.00011	CbGpPWpGaD
Dapagliflozin—UGT2B7—Metabolism—MTHFR—Parkinson's disease	2.42e-05	0.00011	CbGpPWpGaD
Dapagliflozin—UGT1A9—Metabolism—MAOA—Parkinson's disease	2.42e-05	0.00011	CbGpPWpGaD
Dapagliflozin—UGT1A9—Metabolism—HMOX1—Parkinson's disease	2.39e-05	0.000108	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	2.36e-05	0.000107	CbGpPWpGaD
Dapagliflozin—ABCB1—Metabolism—DDC—Parkinson's disease	2.36e-05	0.000107	CbGpPWpGaD
Dapagliflozin—ABCB1—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	2.34e-05	0.000106	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—NDUFB11—Parkinson's disease	2.32e-05	0.000106	CbGpPWpGaD
Dapagliflozin—UGT1A9—Metabolism—ABCB1—Parkinson's disease	2.29e-05	0.000104	CbGpPWpGaD
Dapagliflozin—CYP2A6—Metabolism—CYP2E1—Parkinson's disease	2.26e-05	0.000103	CbGpPWpGaD
Dapagliflozin—UGT2B7—Metabolism—APOE—Parkinson's disease	2.25e-05	0.000102	CbGpPWpGaD
Dapagliflozin—CYP2A6—Metabolism—NQO1—Parkinson's disease	2.24e-05	0.000102	CbGpPWpGaD
Dapagliflozin—UGT1A9—Metabolism—GSTM1—Parkinson's disease	2.23e-05	0.000101	CbGpPWpGaD
Dapagliflozin—ABCB1—Metabolism—GSTA4—Parkinson's disease	2.22e-05	0.000101	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—DDC—Parkinson's disease	2.22e-05	0.000101	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—GCH1—Parkinson's disease	2.22e-05	0.000101	CbGpPWpGaD
Dapagliflozin—CYP2A6—Metabolism—TH—Parkinson's disease	2.21e-05	0.0001	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—DDC—Parkinson's disease	2.2e-05	9.99e-05	CbGpPWpGaD
Dapagliflozin—UGT1A9—Metabolism—GPX1—Parkinson's disease	2.13e-05	9.68e-05	CbGpPWpGaD
Dapagliflozin—CYP2A6—Metabolism—CYCS—Parkinson's disease	2.12e-05	9.62e-05	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—GSTA4—Parkinson's disease	2.1e-05	9.51e-05	CbGpPWpGaD
Dapagliflozin—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—Parkinson's disease	2.09e-05	9.49e-05	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—GSTA4—Parkinson's disease	2.08e-05	9.43e-05	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—Parkinson's disease	2.05e-05	9.31e-05	CbGpPWpGaD
Dapagliflozin—ABCB1—Metabolism—PLA2G6—Parkinson's disease	2e-05	9.09e-05	CbGpPWpGaD
Dapagliflozin—ABCB1—Metabolism—MAOB—Parkinson's disease	1.98e-05	9e-05	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—DBH—Parkinson's disease	1.98e-05	8.97e-05	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—FBP1—Parkinson's disease	1.98e-05	8.97e-05	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—GBA—Parkinson's disease	1.98e-05	8.97e-05	CbGpPWpGaD
Dapagliflozin—UGT1A9—Metabolism—MTHFR—Parkinson's disease	1.97e-05	8.93e-05	CbGpPWpGaD
Dapagliflozin—UGT2B7—Metabolism—INS—Parkinson's disease	1.93e-05	8.74e-05	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—PLA2G6—Parkinson's disease	1.89e-05	8.57e-05	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—DDC—Parkinson's disease	1.88e-05	8.54e-05	CbGpPWpGaD
Dapagliflozin—CYP2A6—Metabolism—COMT—Parkinson's disease	1.88e-05	8.52e-05	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—PLA2G6—Parkinson's disease	1.87e-05	8.49e-05	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—MAOB—Parkinson's disease	1.87e-05	8.48e-05	CbGpPWpGaD
Dapagliflozin—CYP2A6—Metabolism—GSTP1—Parkinson's disease	1.87e-05	8.48e-05	CbGpPWpGaD
Dapagliflozin—CYP2A6—Metabolism—MAOA—Parkinson's disease	1.86e-05	8.46e-05	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—MAOB—Parkinson's disease	1.85e-05	8.41e-05	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism—CYP2D6—Parkinson's disease	1.84e-05	8.37e-05	CbGpPWpGaD
Dapagliflozin—CYP2A6—Metabolism—HMOX1—Parkinson's disease	1.84e-05	8.36e-05	CbGpPWpGaD
Dapagliflozin—UGT1A9—Metabolism—APOE—Parkinson's disease	1.83e-05	8.32e-05	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism—CTGF—Parkinson's disease	1.81e-05	8.22e-05	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—GSTA4—Parkinson's disease	1.78e-05	8.06e-05	CbGpPWpGaD
Dapagliflozin—CYP2A6—Metabolism—ABCB1—Parkinson's disease	1.77e-05	8.02e-05	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	1.76e-05	8e-05	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—Parkinson's disease	1.75e-05	7.96e-05	CbGpPWpGaD
Dapagliflozin—CYP2A6—Metabolism—GSTM1—Parkinson's disease	1.72e-05	7.79e-05	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism—CYP2E1—Parkinson's disease	1.69e-05	7.66e-05	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism—NQO1—Parkinson's disease	1.67e-05	7.57e-05	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism—TH—Parkinson's disease	1.64e-05	7.46e-05	CbGpPWpGaD
Dapagliflozin—CYP2A6—Metabolism—GPX1—Parkinson's disease	1.64e-05	7.46e-05	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—PLA2G6—Parkinson's disease	1.6e-05	7.26e-05	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—MAOB—Parkinson's disease	1.58e-05	7.18e-05	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism—CYCS—Parkinson's disease	1.58e-05	7.17e-05	CbGpPWpGaD
Dapagliflozin—UGT1A9—Metabolism—INS—Parkinson's disease	1.56e-05	7.1e-05	CbGpPWpGaD
Dapagliflozin—CYP2A6—Metabolism—MTHFR—Parkinson's disease	1.52e-05	6.89e-05	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	1.51e-05	6.84e-05	CbGpPWpGaD
Dapagliflozin—ABCB1—Metabolism—CYP2D6—Parkinson's disease	1.47e-05	6.69e-05	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—DDC—Parkinson's disease	1.45e-05	6.59e-05	CbGpPWpGaD
Dapagliflozin—ABCB1—Metabolism—CTGF—Parkinson's disease	1.45e-05	6.57e-05	CbGpPWpGaD
Dapagliflozin—CYP2A6—Metabolism—APOE—Parkinson's disease	1.41e-05	6.41e-05	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism—COMT—Parkinson's disease	1.4e-05	6.35e-05	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism—GSTP1—Parkinson's disease	1.39e-05	6.32e-05	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism—MAOA—Parkinson's disease	1.39e-05	6.3e-05	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—CYP2D6—Parkinson's disease	1.38e-05	6.25e-05	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism—HMOX1—Parkinson's disease	1.37e-05	6.23e-05	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—GSTA4—Parkinson's disease	1.37e-05	6.22e-05	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—CTGF—Parkinson's disease	1.36e-05	6.19e-05	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—CTGF—Parkinson's disease	1.35e-05	6.13e-05	CbGpPWpGaD
Dapagliflozin—ABCB1—Metabolism—CYP2E1—Parkinson's disease	1.35e-05	6.12e-05	CbGpPWpGaD
Dapagliflozin—ABCB1—Metabolism—NQO1—Parkinson's disease	1.33e-05	6.05e-05	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism—ABCB1—Parkinson's disease	1.32e-05	5.98e-05	CbGpPWpGaD
Dapagliflozin—ABCB1—Metabolism—TH—Parkinson's disease	1.31e-05	5.96e-05	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism—GSTM1—Parkinson's disease	1.28e-05	5.8e-05	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—CYP2E1—Parkinson's disease	1.27e-05	5.76e-05	CbGpPWpGaD
Dapagliflozin—ABCB1—Metabolism—CYCS—Parkinson's disease	1.26e-05	5.72e-05	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—CYP2E1—Parkinson's disease	1.26e-05	5.71e-05	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—NQO1—Parkinson's disease	1.26e-05	5.7e-05	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—NQO1—Parkinson's disease	1.24e-05	5.65e-05	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—TH—Parkinson's disease	1.24e-05	5.62e-05	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—PLA2G6—Parkinson's disease	1.23e-05	5.6e-05	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—TH—Parkinson's disease	1.23e-05	5.57e-05	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism—GPX1—Parkinson's disease	1.22e-05	5.56e-05	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—MAOB—Parkinson's disease	1.22e-05	5.54e-05	CbGpPWpGaD
Dapagliflozin—CYP2A6—Metabolism—INS—Parkinson's disease	1.21e-05	5.48e-05	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—CYCS—Parkinson's disease	1.19e-05	5.39e-05	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—CYCS—Parkinson's disease	1.18e-05	5.35e-05	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—CYP2D6—Parkinson's disease	1.18e-05	5.34e-05	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—CTGF—Parkinson's disease	1.15e-05	5.24e-05	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism—MTHFR—Parkinson's disease	1.13e-05	5.13e-05	CbGpPWpGaD
Dapagliflozin—ABCB1—Metabolism—COMT—Parkinson's disease	1.12e-05	5.07e-05	CbGpPWpGaD
Dapagliflozin—ABCB1—Metabolism—GSTP1—Parkinson's disease	1.11e-05	5.05e-05	CbGpPWpGaD
Dapagliflozin—ABCB1—Metabolism—MAOA—Parkinson's disease	1.11e-05	5.03e-05	CbGpPWpGaD
Dapagliflozin—ABCB1—Metabolism—HMOX1—Parkinson's disease	1.1e-05	4.98e-05	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—CYP2E1—Parkinson's disease	1.08e-05	4.88e-05	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—NQO1—Parkinson's disease	1.06e-05	4.83e-05	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—COMT—Parkinson's disease	1.05e-05	4.78e-05	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism—APOE—Parkinson's disease	1.05e-05	4.78e-05	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—TH—Parkinson's disease	1.05e-05	4.76e-05	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—GSTP1—Parkinson's disease	1.05e-05	4.75e-05	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—MAOA—Parkinson's disease	1.04e-05	4.74e-05	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—COMT—Parkinson's disease	1.04e-05	4.74e-05	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—GSTP1—Parkinson's disease	1.04e-05	4.71e-05	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—MAOA—Parkinson's disease	1.04e-05	4.7e-05	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—HMOX1—Parkinson's disease	1.03e-05	4.69e-05	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—HMOX1—Parkinson's disease	1.02e-05	4.65e-05	CbGpPWpGaD
Dapagliflozin—ABCB1—Metabolism—GSTM1—Parkinson's disease	1.02e-05	4.64e-05	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—CYCS—Parkinson's disease	1.01e-05	4.57e-05	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—ABCB1—Parkinson's disease	9.91e-06	4.5e-05	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—ABCB1—Parkinson's disease	9.83e-06	4.46e-05	CbGpPWpGaD
Dapagliflozin—ABCB1—Metabolism—GPX1—Parkinson's disease	9.78e-06	4.44e-05	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—GSTM1—Parkinson's disease	9.62e-06	4.37e-05	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—GSTM1—Parkinson's disease	9.54e-06	4.33e-05	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—GPX1—Parkinson's disease	9.22e-06	4.18e-05	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—GPX1—Parkinson's disease	9.14e-06	4.15e-05	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—CYP2D6—Parkinson's disease	9.08e-06	4.12e-05	CbGpPWpGaD
Dapagliflozin—ABCB1—Metabolism—MTHFR—Parkinson's disease	9.03e-06	4.1e-05	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism—INS—Parkinson's disease	8.99e-06	4.08e-05	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—COMT—Parkinson's disease	8.91e-06	4.05e-05	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—CTGF—Parkinson's disease	8.91e-06	4.04e-05	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—GSTP1—Parkinson's disease	8.87e-06	4.03e-05	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—MAOA—Parkinson's disease	8.85e-06	4.02e-05	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—HMOX1—Parkinson's disease	8.75e-06	3.97e-05	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—MTHFR—Parkinson's disease	8.5e-06	3.86e-05	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—MTHFR—Parkinson's disease	8.43e-06	3.83e-05	CbGpPWpGaD
Dapagliflozin—ABCB1—Metabolism—APOE—Parkinson's disease	8.4e-06	3.81e-05	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—ABCB1—Parkinson's disease	8.4e-06	3.81e-05	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—CYP2E1—Parkinson's disease	8.3e-06	3.77e-05	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—NQO1—Parkinson's disease	8.21e-06	3.73e-05	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—GSTM1—Parkinson's disease	8.15e-06	3.7e-05	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—TH—Parkinson's disease	8.09e-06	3.67e-05	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—APOE—Parkinson's disease	7.92e-06	3.59e-05	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—APOE—Parkinson's disease	7.85e-06	3.56e-05	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—GPX1—Parkinson's disease	7.81e-06	3.54e-05	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—CYCS—Parkinson's disease	7.77e-06	3.53e-05	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—MTHFR—Parkinson's disease	7.2e-06	3.27e-05	CbGpPWpGaD
Dapagliflozin—ABCB1—Metabolism—INS—Parkinson's disease	7.18e-06	3.26e-05	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—COMT—Parkinson's disease	6.88e-06	3.12e-05	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—GSTP1—Parkinson's disease	6.85e-06	3.11e-05	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—MAOA—Parkinson's disease	6.83e-06	3.1e-05	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—INS—Parkinson's disease	6.76e-06	3.07e-05	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—HMOX1—Parkinson's disease	6.75e-06	3.07e-05	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—APOE—Parkinson's disease	6.71e-06	3.05e-05	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—INS—Parkinson's disease	6.71e-06	3.04e-05	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—ABCB1—Parkinson's disease	6.48e-06	2.94e-05	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—GSTM1—Parkinson's disease	6.29e-06	2.86e-05	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—GPX1—Parkinson's disease	6.03e-06	2.74e-05	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—INS—Parkinson's disease	5.73e-06	2.6e-05	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—MTHFR—Parkinson's disease	5.56e-06	2.52e-05	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—APOE—Parkinson's disease	5.18e-06	2.35e-05	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—INS—Parkinson's disease	4.42e-06	2.01e-05	CbGpPWpGaD
